The expression of LRP6 had no correlation with the clinical characteristics of gastric cancer patients, while its co-expression with SERPINF1 was correlated with the cancer malignant phenotype, which indicated the role of SERPINF1–LRP6 interaction during tumor progression. Here, SERPINF1 is linked to neoplasm.